Affiliation:
1. Department of Electrical and Computer Engineering, Sungkyunkwan University, Gyeonggi, Suwon 16419, Republic of Korea
2. Clinical Research Group, Samsung Healthcare, Gangdong-gu, Seoul 05340, Republic of Korea
Abstract
Despite tremendous developments in continuous blood glucose measurement (CBGM) sensors, they are still not accurate for all patients with diabetes. As glucose concentration in the blood is <1% of the total blood volume, it is challenging to accurately measure glucose levels in the interstitial fluid using CBGM sensors due to within-patient and between-patient variations. To address this issue, we developed a novel data-driven approach to accurately predict CBGM values using personalized calibration and machine learning. First, we scientifically divided measured blood glucose into smaller groups, namely, hypoglycemia (<80 mg/dL), nondiabetic (81–115 mg/dL), prediabetes (116–150 mg/dL), diabetes (151–181 mg/dL), severe diabetes (181–250 mg/dL), and critical diabetes (>250 mg/dL). Second, we separately trained each group using different machine learning models based on patients’ personalized parameters, such as physical activity, posture, heart rate, breath rate, skin temperature, and food intake. Lastly, we used multilayer perceptron (MLP) for the D1NAMO dataset (training to test ratio: 70:30) and grid search for hyperparameter optimization to predict accurate blood glucose concentrations. We successfully applied our proposed approach in nine patients with type 1 diabetes and observed that the mean absolute relative difference (MARD) decreased from 17.8% to 8.3%.
Reference34 articles.
1. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045;Sun;Diabetes Res. Clin. Pract.,2022
2. International Diabetes Federation (IDF) (2022, September 20). IDF Diabetes Atlas. Available online: https://diabetesatlas.org/atlas/tenth-edition/.
3. American Diabetes Association (2005). Diagnosis and classification of diabetes mellitus. Diabetes Care, 28, S37.
4. (2021, June 07). Global Diabetes Diagnostics Market to Reach $41.9 Billion by 2027. Statistic. Available online: https://www.strategyr.com/market-report-diabetes-diagnostics-forecasts-global-industry-analysts-inc.
5. Trends in nanomaterial-based noninvasive diabetes sensing technologies;Makaram;Diagnostics,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献